我还要背着他 发表于 2025-3-28 16:02:42

Esophageal Cancer,000) is lower than the global average (9.3/100,000) . Among the two histological subtypes, esophageal squamous cell carcinoma (ESCC), which occurs most frequently in the proximal two-thirds region of the esophagus, constitutes 87%, while esophageal adenocarcinoma (EAC), mostly observed in the dis

progestogen 发表于 2025-3-28 20:09:08

http://reply.papertrans.cn/19/1881/188001/188001_42.png

OCTO 发表于 2025-3-29 01:03:23

Colorectal Cancer,ncidence rate is roughly four times higher compared to that of transitioning countries . Europe has the highest prevalence rates of colon cancer, followed by Australia/New Zealand and Northern America . Hungary and Norway rank first among men and women, respectively . Rectal cancer is more

战胜 发表于 2025-3-29 06:22:41

http://reply.papertrans.cn/19/1881/188001/188001_44.png

Trigger-Point 发表于 2025-3-29 11:10:48

http://reply.papertrans.cn/19/1881/188001/188001_45.png

清楚说话 发表于 2025-3-29 12:08:55

http://reply.papertrans.cn/19/1881/188001/188001_46.png

使人烦燥 发表于 2025-3-29 16:33:13

Kidney Cancer,ew cases were reported, accounting for 2.2% of all cancer cases . The incidence and mortality rates were highest in Eastern Asia (108,503 cases and 54,658 deaths), followed by Northern America (76,975 cases and 16,791 deaths), and Central and Eastern Europe (49,772 cases and 20,238 deaths) . F

BRUNT 发表于 2025-3-29 23:40:15

http://reply.papertrans.cn/19/1881/188001/188001_48.png

exercise 发表于 2025-3-30 00:21:22

http://reply.papertrans.cn/19/1881/188001/188001_49.png

跑过 发表于 2025-3-30 06:47:32

Prostate Cancer,ifth in mortality with 3,75,304 deaths accounting to 6.8% of all cancer-related deaths globally. In more than half of the world, i.e., 112 out of 185 countries, the most diagnosed cancer was prostate cancer . Incidence rates of PCa were three times higher in transitioned countries than in transit
页: 1 2 3 4 [5] 6 7
查看完整版本: Titlebook: Biomedical Aspects of Solid Cancers; Rama Krishna Kancha Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive licens